JM Innovations



National & World Ag News Headlines
CDC Tool Maps Antibiotic Resistance Progress, But More Needed
USAgNet - 01/12/2018

The Centers for Disease Control and Prevention (CDC) released new data in its Antibiotic Resistance (AR) Investment Map, which shows early progress by states to combat AR. This year's AR Investment Map features more than 170 state-reported successes--like rapidly identifying and containing rare and concerning resistant germs to protect communities. Each state reported multiple successes. These are the first comprehensive reports on state progress made following the first year of Congress' unprecedented investment in CDC's Antibiotic Resistance Solutions Initiative.

The AR Investment Map displays CDC's AR activities in printable state- and city-specific fact sheets, providing a comprehensive view of CDC's resources to protect Americans from antibiotic-resistant infections. Antibiotic resistance occurs when germs no longer respond to the drugs designed to kill them. Some germs already have become resistant to all available antibiotics, making some completely untreatable.

"Antibiotic resistance has the potential to impact all Americans at every stage of life," said CDC Director Brenda Fitzgerald, M.D. "This interactive map showcases the work happening on the frontlines of every state and CDC's commitment to keep people safe from drug-resistant infections."

In fiscal year 2016, CDC made investments in all 50 states, six large cities, and Puerto Rico to enhance laboratory and epidemiology expertise and grow public health innovations to fight antibiotic resistance across healthcare settings, food, and communities.

These investments helped states like Oklahoma and Connecticut each successfully identify and contain a single case of Candida auris, a multidrug-resistant fungus that can cause deadly infections.

Early progress shows antibiotic resistance investments are working

Send this article to a friend


Other National Headlines
Pipping Concrete
Zabel Equipment
Copyright 2018 - USAgNet.com. All Rights Reserved.